BIOGRAPHY
Gulfaraz Khan is Professor of Viral Pathology in the Department of Microbiology & Immunology. He did his undergraduate and postgraduate training in London, followed by postdoctoral training at Tufts University School of Medicine and University of Glasgow. He held faculty positions in universities in UK before moving to his current post in UAE. He has extensive experience in research, teaching and training postgraduate students. He has FRCPath in Virology.
Dr Khan’s primary research interests are in viral pathology and infectious diseases. His secondary interests are in emerging viral infections and public health. His publication statistics: 125 papers in high impact journals, 1 book, 10 book chapters, H-index: 57, i-10-index: 99, citations: >60,000.
Dr Khan has received numerous awards for his teaching and research, including the College and University Awards for Excellence in Scholarship. He was a nominee for the UAE Prime Minister’s Medal for Scientific Excellence, and is an elected member of the UAE Mohammad bin Rashid Academy of Scientists. He serves on the editorial board of several international journals.
In 2020, he was appointed to the MENA Regional Advisory Panel for US NIH-NIAID. He has been included in the Stanford list of top 2% scientists for the last 3 consecutive years.
EDUCATION
-
Doctorate Degree, Doctor of Philosophy, Medical Sciences, University of London, 1993
RESEARCH AREAS
- Epstein-Barr virus
- Viral Pathology
- Infectious Diseases
- Emerging viral infections and public health
RECENT PUBLICATIONS
-
(2022). "The overlapping burden of the three leading causes of disability and death in sub-Saharan African children". Co-Authors: Welgan CA, Troeger CE, Baumann MM, Weiss DJ//Khan G et al
. Nature Communications. 13.
-
(2022). "What do animal models tell us about the role of EBV in the pathogenesis of multiple sclerosis?". Co-Authors: Hassani A, Khan G
. Front Immunol. 13.
-
(2022). "Stem-loop 1 of Epstein-Barr virus-encoded RNA1 is involved in upregulating CDT1 expression and inducing cell proliferation". Co-Authors: Hassan Z, Philip PS, Khan G
. Viruses. 14.
-
(2022). "Somatotopic localization of c-Fos expression in the spinal cord in response to noxious heat sensation". Co-Authors: Shehab S, Javed H, Khan G
. Front Neuroanat. 16.
-
(2022). "Crimean–Congo hemorrhagic fever in the Arab world: A systematic review". Co-Authors: Perveen G, Khan G
. Front Vet Sc. 9.
-
(2022). "Novel Automated Artificial Intelligence-Enabled Proactive Preparedness Real-time System for Accurate Prediction of COVID-19 Infections -Performance Evaluation". Co-Authors: Ismail L, Materwala H, Al Hammadi H, Firouzi F, Khan G, Razalli S
. Front Medicine. 9.
-
(2021). "Primary Peripheral Epstein-Barr Virus Infection Can Lead to CNS Infection and Neuroinflammation in a Rabbit Model: Implications for Multiple Sclerosis Pathogenesis ". Co-Authors: Hassani A; Reguraman N; Shehab S; Khan G. Front Immunol . 12.
-
(2021). "Uncovering Early Events in Primary Epstein-Barr Virus Infection Using a Rabbit Model". Co-Authors: Reguraman N; Hassani A; Philip P; Khan G. Scientific Reports . 11.
-
(2021). "Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990-2019, for 204 countries and territories: the Global Burden of Diseases ". Co-Authors: Jahagirdar D; Walters MK; Novotney A//Khan G et al.. Lancet HIV . .
-
(2021). "Serological Assays for Assessing Postvaccination SARS-CoV-2 Antibody Response". Co-Authors: Mahmoud SA; Ganesan S; Naik S; Bissar S; Zamel IA; Warren KN; Zaher WA; Khan G. . Microbiol Spectrum . .
